This observation may be relevant to the understanding of the pathogenesis of hyperglycemia in T1D and to the observation that ABA improves insulin action in insulin-deficient mice: the demise of beta-cells in T1D would compromise the production of both glycemia-reducing hormones, insulin and ABA, only one of which is being provided by current therapeutic protocols. Here, INS is linked to type 1 diabetes mellitus.